Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

Finasteride can slow hair loss and promote growth in postmenopausal women.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

CBG may help with various medical conditions but needs more human research to confirm safety and effectiveness.

Phyto-vesicles of β-sitosterol may effectively treat hair loss.

Minoxidil and spironolactone combo effectively treats androgenetic alopecia, improving hair density and diameter.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

PRGF treatment is safer and more effective for hair loss than topical minoxidil.

PRGF treatment safely and effectively helps hair loss.

Androgens reduce BMP2, which weakens the ability of certain cells to help hair stem cells become different types of cells.

Adding licorice gel to laser treatment is more effective for reducing facial hair than laser alone.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Understanding gender differences and individual patient characteristics is essential for optimal cosmetic surgery outcomes.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.